Compare IEAG & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IEAG | FENC |
|---|---|---|
| Founded | 2025 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 443.0M | 470.6M |
| IPO Year | 2025 | 2010 |
| Metric | IEAG | FENC |
|---|---|---|
| Price | $10.13 | $13.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $17.60 |
| AVG Volume (30 Days) | 121.4K | ★ 255.2K |
| Earning Date | N/A | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | N/A | ★ $44,642,000.00 |
| Revenue This Year | N/A | $67.04 |
| Revenue Next Year | N/A | $44.54 |
| P/E Ratio | ★ N/A | $70.79 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.97 | $5.65 |
| 52 Week High | $10.30 | $13.85 |
| Indicator | IEAG | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 55.77 | 62.70 |
| Support Level | $9.98 | $9.58 |
| Resistance Level | $10.18 | $12.79 |
| Average True Range (ATR) | 0.03 | 0.92 |
| MACD | 0.01 | 0.31 |
| Stochastic Oscillator | 100.00 | 77.10 |
Infinite Eagle Acquisition Corp is a blank check company.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.